Avoca Inc (AVOA) 1,955.0000 $AVOA
Avoca Signs Supply Agreement with Synthetic Genomics, Inc. to Become Domestic Source of Natural Astaxanthin
PR Newswire - Fri Jun 20, 9:00AM CDT
Avoca, Inc., a division of Pharmachem Laboratories, Inc., has formed a supply agreement with Synthetic Genomics, Inc. (SGI), a privately held company developing and commercializing genomic driven solutions and products in a variety of industries, to extract and commercialize natural astaxanthin from a strain of algae developed by SGI. The multi-year supply agreement also provides Avoca with exclusivity for product sales in North America. Pharmachem Laboratories will be responsible for marketing and sales. SGI is developing this product through their Genovia Bio business unit, which is responsible for the development and commercialization of algal-based food, chemical and fuel products. Financial details were not disclosed.
A Hedged Play on the Booming Electronic Cigarette Market
Rupert Hargreaves, The Motley Fool - Motley Fool - Mon Jan 06, 12:40PM CST
Once described as the most disruptive technology of the century (or at least the most disruptive to the tobacco industry), electronic cigarettes have proven to be one of the most successful products to hit the market in the past few years. Indeed,...
Process Manufacturer Avoca Selects TabWare CMMS/EAM Solution for Maintenance Management
PRWeb - Wed Aug 21, 8:11AM CDT
AssetPoint, a leading provider of (EAM) Enterprise Asset Management and (CMMS) Computerized Maintenance Management Software solutions, announced Avoca Inc. has selected TabWare CMMS/EAM solution for maintenance management of their three extraction and fermentation facilities.
Tobacco supplier Universal to make liquid nicotine
AP - Wed Aug 07, 8:36AM CDT
RICHMOND, Va. (AP) — Tobacco leaf supplier Universal Corporation is launching a joint venture to produce liquid nicotine for the electronic cigarette industry.
Universal Corporation Announces Joint Venture to Produce Liquid Nicotine
PR Newswire - Tue Aug 06, 1:01PM CDT
Universal Corporation (NYSE: UVV), the leading global leaf tobacco supplier, announced today that its subsidiary, Virginia Tobacco Company, Inc., has joined Avoca, Inc., one of the world's premier botanical extraction companies, in the formation of AmeriNic, Inc. to produce liquid nicotine for the electronic cigarette industry. This new business will produce high quality, United States Pharmacopeia (USP) grade liquid nicotine in the United States using fully traceable and compliant tobaccos. AmeriNic, Inc. expects to begin production of liquid nicotine before the end of the calendar year.
The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation Based on Neptune & Acasti Complaint
GlobeNewswire - Mon Apr 15, 7:00AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune"
(Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti" (Nasdaq:ACST) (TSX-V:APO), a Neptune subsidiary, announce that the U.S. International Trade Commission has voted to institute an investigation of alleged patent infringements by Aker BioMarine AS; Aker BioMarine Antarctic USA, Inc.; Aker BioMarine Antarctic AS; Enzymotec Limited; Enzymotec USA, Inc.; Olympic Seafood AS; Olympic Biotec Ltd.; Avoca, Inc.; Rimfrost USA, LLC and Bioriginal Food & Science Corp. (collectively the "Respondents" .
Avoca Signs Supply Agreement with Synthetic Genomics, Inc. to Become Domestic Source of Natural Astaxanthin
PR Newswire - Fri Jun 20, 9:00AM CDT
Avoca, Inc., a division of Pharmachem Laboratories, Inc., has formed a supply agreement with Synthetic Genomics, Inc. (SGI), a privately held company developing and commercializing genomic driven solutions and products in a variety of industries, to extract and commercialize natural astaxanthin from a strain of algae developed by SGI. The multi-year supply agreement also provides Avoca with exclusivity for product sales in North America. Pharmachem Laboratories will be responsible for marketing and sales. SGI is developing this product through their Genovia Bio business unit, which is responsible for the development and commercialization of algal-based food, chemical and fuel products. Financial details were not disclosed.
A Hedged Play on the Booming Electronic Cigarette Market
Rupert Hargreaves, The Motley Fool - Motley Fool - Mon Jan 06, 12:40PM CST
Once described as the most disruptive technology of the century (or at least the most disruptive to the tobacco industry), electronic cigarettes have proven to be one of the most successful products to hit the market in the past few years. Indeed,...
Process Manufacturer Avoca Selects TabWare CMMS/EAM Solution for Maintenance Management
PRWeb - Wed Aug 21, 8:11AM CDT
AssetPoint, a leading provider of (EAM) Enterprise Asset Management and (CMMS) Computerized Maintenance Management Software solutions, announced Avoca Inc. has selected TabWare CMMS/EAM solution for maintenance management of their three extraction and fermentation facilities.
Tobacco supplier Universal to make liquid nicotine
AP - Wed Aug 07, 8:36AM CDT
RICHMOND, Va. (AP) — Tobacco leaf supplier Universal Corporation is launching a joint venture to produce liquid nicotine for the electronic cigarette industry.
Universal Corporation Announces Joint Venture to Produce Liquid Nicotine
PR Newswire - Tue Aug 06, 1:01PM CDT
Universal Corporation (NYSE: UVV), the leading global leaf tobacco supplier, announced today that its subsidiary, Virginia Tobacco Company, Inc., has joined Avoca, Inc., one of the world's premier botanical extraction companies, in the formation of AmeriNic, Inc. to produce liquid nicotine for the electronic cigarette industry. This new business will produce high quality, United States Pharmacopeia (USP) grade liquid nicotine in the United States using fully traceable and compliant tobaccos. AmeriNic, Inc. expects to begin production of liquid nicotine before the end of the calendar year.
The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation Based on Neptune & Acasti Complaint
GlobeNewswire - Mon Apr 15, 7:00AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune"
(Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti" (Nasdaq:ACST) (TSX-V:APO), a Neptune subsidiary, announce that the U.S. International Trade Commission has voted to institute an investigation of alleged patent infringements by Aker BioMarine AS; Aker BioMarine Antarctic USA, Inc.; Aker BioMarine Antarctic AS; Enzymotec Limited; Enzymotec USA, Inc.; Olympic Seafood AS; Olympic Biotec Ltd.; Avoca, Inc.; Rimfrost USA, LLC and Bioriginal Food & Science Corp. (collectively the "Respondents" . 
